Trial NCT03593213

View at ClinicalTrials.gov 
Aliases: NCT04519099
Org. Study IDs: RGH-MD-24
Secondary IDs: 2017-000818-34

Last trial update was posted on 2022-04-11

MeSH Interventions

Cariprazine

MeSH Conditions

Schizophrenia

Other Conditions


Stopping Reasons

FDA Released Allergan from this post marketing requirement

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID